Bioorganic and Medicinal Chemistry Letters p. 3583 - 3588 (1998)
Update date:2022-08-03
Topics:
Ambler, John
Baker, Emma
Brown, Lyndon
Butler, Paul
Farr, Dave
Dunnet, Karen
Le Grand, Darren
Janus, Diana
Jones, Darryl
Menear, Keith
Mercer, Mark
Smith, Garrick
Talbot, Mark
Tweed, Morris
The chemical optimisation of CGH1668 1 is described employing an in vivo model of absorption to determine the influence on bioavailability of single point modifications to five key molecular templates. The discovery of an orally bioavailable and selective thrombin inhibitor, 24, highlights the utility of this approach.
View MoreContact:18710867521(wechat)
Address:Rm10516,Galaxy Tech Building #2,No.25 Tangyan Rd,Hi-Tech Zone,Xi'an, China
Kaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
Wuhan Yitongtai Science and Technology Co.,Ltd.
Contact:+86-27-88933550
Address:27th Fl. Bldg. 1, Shuian International Mansion, Heping Ave, Wuhan, Hubei, China
Taizhou Sunny Chemical Co.,Ltd
Contact:+86-523-86920899 +86-13951172783
Address:No.11 Xingyuang road, Gaoyong Chemical Industry Park, Gaogang Jiangsu China
Junkai (Tianjin) Chemical Co., Ltd.
website:http://www.junkaichem.com
Contact:86-22-85689515
Address:Room 8-501, Building K2, The Hi-Tech Green Industrial Base, No.6, 6th Road, Hi-Tech Development Road, Tianjin Hi-Tech IndustrialPark, Tianjin, China.
Doi:10.1016/j.tet.2010.05.054
(2010)Doi:10.1039/a705571d
(1997)Doi:10.1007/BF02291796
(1997)Doi:10.1021/jm00301a034
(1969)Doi:10.1039/DT9950002923
(1995)Doi:10.1021/jo060129c
(2006)